SEC Mandates Activist Investors Disclose Client Identities in Filings

The U.S. Securities and Exchange Commission (SEC) has issued new guidance requiring activist investors to disclose the identities of their clients in key regulatory filings. This significant move, aimed at increasing transparency, could impact how activist hedge funds finance and conduct campaigns to influence corporate strategy.

New Disclosure Requirements

In an updated interpretation of its rules published Thursday, the SEC clarified its stance on disclosures for Schedule 13D filings and proxy statements. The guidance specifically targets the anonymity of investors backing activist campaigns, particularly those using special-purpose vehicles.

According to the SEC's updated Corporate Finance Interpretations:

• The identities of investors in an entity "formed for the purpose of acquiring securities of a specific issuer and engaging in an activism campaign" must be disclosed (Question 110.09).
• Clients of a limited partnership are considered "participants" in a proxy solicitation if they have invested more than $500 for the purpose of changing board directors (Question 155.02).

Implications for Activist Funds

Ad

The new interpretation directly challenges the long-held practice of secrecy among activist hedge funds, which have historically argued that revealing their limited partners could compromise their investment strategies and competitive edge. The guidance is particularly relevant given the growing use of special purpose vehicles, or "sidecars," which allow clients to invest in specific corporate targets rather than a fund's broader portfolio.

While activist funds may view this as a hurdle, corporations targeted by activists have long advocated for greater transparency. They argue that knowing the ultimate source of funding is critical for shareholders to evaluate a campaign and for the company to formulate a response.

Context and Precedent

The SEC's move comes after a busy first half of 2026 for shareholder activism, with campaigns at major companies like Warner Bros Discovery and Devon Energy. The debate over investor disclosure is not new. In 2022, medical device maker Masimo Corp. famously amended its bylaws to force activists to disclose their limited partners, a move that sparked significant backlash and was later reversed in early 2023.

The SEC’s new guidance now provides a federal regulatory stance on an issue that was previously contested on a company-by-company basis, potentially standardizing a new level of disclosure across the industry.